| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J0178 |
Injection, aflibercept, 1 mg |
5,112 |
4,243 |
$5.48M |
| 67028 |
Intravitreal injection of a pharmacologic agent |
14,286 |
12,271 |
$473K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
9,164 |
8,216 |
$337K |
| J2778 |
Injection, ranibizumab, 0.1 mg |
321 |
289 |
$250K |
| 92134 |
|
16,271 |
14,359 |
$195K |
| J2777 |
Injection, faricimab-svoa, 0.1 mg |
239 |
179 |
$179K |
| J9035 |
Injection, bevacizumab, 10 mg |
2,361 |
2,031 |
$142K |
| 92250 |
|
8,775 |
7,850 |
$127K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
2,016 |
1,812 |
$114K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
1,327 |
1,201 |
$41K |
| 67228 |
|
151 |
134 |
$18K |
| 92235 |
|
303 |
280 |
$11K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
62 |
62 |
$3K |
| J7999 |
Compounded drug, not otherwise classified |
12 |
12 |
$388.04 |
| 99072 |
|
744 |
657 |
$0.00 |
| 99024 |
|
14 |
12 |
$0.00 |